Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that DR10624, its ...
At the Huawei Product & Solution Launch during MWC Barcelona 2025, Cao Ming, Vice President of Huawei and President of Huawei ...
Sun Pharmaceuticals will acquire Checkpoint Therapeutics for $355 million, bringing the FDA-approved anti-PD-L1 treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback